Cite
HARVARD Citation
Rheingold, S. et al. (2017). A phase 1 trial of temsirolimus and intensive re‐induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114). British journal of haematology. pp. 467-474. [Online].